Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
3.460
-0.080 (-2.26%)
Jan 23, 2025, 10:29 AM EST - Market open
Cardiff Oncology Employees
As of December 31, 2023, Cardiff Oncology had 32 total employees, including 31 full-time and 1 part-time employees. The number of employees increased by 6 or 23.08% compared to the previous year.
Employees
32
Change (1Y)
6
Growth (1Y)
23.08%
Revenue / Employee
$21,500
Profits / Employee
-$1,343,906
Market Cap
230.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
CRDF News
- 5 weeks ago - Undercovered Dozen: Ubiquiti, Ready Capital, Cardiff Oncology, Vodafone + - Seeking Alpha
- 6 weeks ago - Cardiff Oncology: The Long-Awaited First-Line MCRC Data Are Here, But The Work Is Just Beginning - Seeking Alpha
- 6 weeks ago - Cardiff Oncology: Beats Standard Of Care In First Line Metastatic Colorectal Cancer - Seeking Alpha
- 6 weeks ago - Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct Offering - GlobeNewsWire
- 6 weeks ago - Cardiff Oncology Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial - GlobeNewsWire
- 3 months ago - Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC - GlobeNewsWire
- 3 months ago - Cardiff Oncology: Paramount Data Imminent In Huge First-Line mCRC Market - Seeking Alpha
- 5 months ago - Cardiff: Second Half Of 2024 mCRC Data Is Major Inflection Point - Seeking Alpha